Aortic stenosis cost-effectiveness of therapy: Difference between revisions
Rim Halaby (talk | contribs) No edit summary |
No edit summary |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{| class="infobox" style="float:right;" | |||
|- | |||
| [[File:Siren.gif|30px|link=Aortic stenosis resident survival guide]]|| <br> || <br> | |||
| [[Aortic stenosis resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] | |||
|} | |||
{{Aortic stenosis}} | {{Aortic stenosis}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
[[Transcatheter aortic valve implantation]] (TAVI) is more cost-effective compared to medical management among aortic stenosis patients unsuitable for surgery. Among patients suitable for surgery, surgical aortic valve replacement is more cost-effective than TAVI.<ref name="pmid23948359">{{cite journal| author=Orlando R, Pennant M, Rooney S, Khogali S, Bayliss S, Hassan A et al.| title=Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. | journal=Health Technol Assess | year= 2013 | volume= 17 | issue= 33 | pages= 1-86 | pmid=23948359 | doi=10.3310/hta17330 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23948359 }} </ref> | |||
==Cost-effectiveness of Therapy== | |||
[[Transcatheter aortic valve implantation]] (TAVI) is more cost-effective compared to medical management among aortic stenosis patients unsuitable for surgery. Among patients suitable for surgery, surgical aortic valve replacement is more cost-effective than TAVI.<ref name="pmid23948359">{{cite journal| author=Orlando R, Pennant M, Rooney S, Khogali S, Bayliss S, Hassan A et al.| title=Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. | journal=Health Technol Assess | year= 2013 | volume= 17 | issue= 33 | pages= 1-86 | pmid=23948359 | doi=10.3310/hta17330 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23948359 }} </ref> | [[Transcatheter aortic valve implantation]] (TAVI) is more cost-effective compared to medical management among aortic stenosis patients unsuitable for surgery. Among patients suitable for surgery, surgical aortic valve replacement is more cost-effective than TAVI.<ref name="pmid23948359">{{cite journal| author=Orlando R, Pennant M, Rooney S, Khogali S, Bayliss S, Hassan A et al.| title=Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation. | journal=Health Technol Assess | year= 2013 | volume= 17 | issue= 33 | pages= 1-86 | pmid=23948359 | doi=10.3310/hta17330 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23948359 }} </ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[CME Category::Cardiology]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
| Line 16: | Line 28: | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
Latest revision as of 15:52, 6 March 2020
 |
Resident Survival Guide |
|
Aortic Stenosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Percutaneous Aortic Balloon Valvotomy (PABV) or Aortic Valvuloplasty |
|
Transcatheter Aortic Valve Replacement (TAVR) |
|
Case Studies |
|
Aortic stenosis cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Aortic stenosis cost-effectiveness of therapy |
|
Directions to Hospitals Treating Aortic stenosis cost-effectiveness of therapy |
|
Risk calculators and risk factors for Aortic stenosis cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Transcatheter aortic valve implantation (TAVI) is more cost-effective compared to medical management among aortic stenosis patients unsuitable for surgery. Among patients suitable for surgery, surgical aortic valve replacement is more cost-effective than TAVI.[1]
Cost-effectiveness of Therapy
Transcatheter aortic valve implantation (TAVI) is more cost-effective compared to medical management among aortic stenosis patients unsuitable for surgery. Among patients suitable for surgery, surgical aortic valve replacement is more cost-effective than TAVI.[1]
References
- ↑ 1.0 1.1 Orlando R, Pennant M, Rooney S, Khogali S, Bayliss S, Hassan A; et al. (2013). "Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation". Health Technol Assess. 17 (33): 1–86. doi:10.3310/hta17330. PMID 23948359.